Top

Published in:

01-02-2022 | Long-COVID Syndrome | Review Article

Long COVID from rheumatology perspective — a narrative review

Authors: Hem Raj Sapkota, Arvind Nune

Published in: Clinical Rheumatology | Issue 2/2022

Abstract

Long-term sequel of acute COVID-19, commonly referred to as long COVID, has affected millions of patients worldwide. Long COVID patients display persistent or relapsing and remitting symptoms that include fatigue, breathlessness, cough, myalgia, arthralgia, sleep disturbance, cognitive impairment and skin rashes. Due to the shared clinical features, laboratory and imaging findings, long COVID could mimic rheumatic disease posing a diagnostic challenge. Our comprehensive literature review will help rheumatologist to be aware of long COVID manifestations and differentiating features from rheumatic diseases to ensure a timely and correct diagnosis is reached.

Hickie I, Davenport T, Wakefield D et al (2006) Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 333(7568):575. https://doi.org/10.1136/bmj.38933.585764.AECrossRefPubMedPubMedCentral

Parums DV (2021) Editorial: long COVID, or post-COVID syndrome, and the global impact on health care. Med Sci Monit 27:e933446. https://doi.org/10.12659/MSM.933446 (Published 2021 Jun 7)CrossRefPubMedPubMedCentral

ONS 2021 (Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 9/09/2021 access. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/2september2021

Beeching NJ, Fletcher TE, Beadsworth MBJ (2020) Covid-19: testing times. BMJ. 369:m1403. https://doi.org/10.1136/bmj.m1403 (Published 2020 Apr 8)CrossRefPubMed

Moreno-Pérez O, Merino E, Leon-Ramirez JM et al (2021) Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect 82(3):378–383. https://doi.org/10.1016/j.jinf.2021.01.004CrossRefPubMedPubMedCentral

Mandal S, Barnett J, Brill SE et al (2021) ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax 76(4):396–398. https://doi.org/10.1136/thoraxjnl-2020-215818CrossRefPubMed

Fernández-de-Las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Cuadrado ML, Florencio LL (2021) Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Int J Environ Res Public Health 18(5):2621. https://doi.org/10.3390/ijerph18052621 (Published 2021 Mar 5)CrossRefPubMedPubMedCentral

Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L (2020) Management of post-acute covid-19 in primary care. BMJ 370:m3026. https://doi.org/10.1136/bmj.m3026 (Published 2020 Aug 11)CrossRefPubMed

National Institute for Health and Care Excellence(NICE) (2020) COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline [NG188] . Published Dec 2020. Available at (https://www.nice.org.uk/guidance/gid-ng10179/documents/final-scope) accessed 28/12/ 2020

10.

World Health Organisation (WHO) (2021) A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. Available at https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 Accessed 25/10/2021

11.

Mahase E (2020) Covid-19: two antibody tests are “highly specific” but vary in sensitivity, evaluations find. BMJ 369:m2066. https://doi.org/10.1136/bmj.m2066 (Published 2020 May 21)CrossRefPubMed

12.

Falahi S, Kenarkoohi A (2020) COVID-19 reinfection: prolonged shedding or true reinfection? New Microbes New Infect 38:100812. https://doi.org/10.1016/j.nmni.2020.100812CrossRefPubMedPubMedCentral

13.

Ladds E, Rushforth A, Wieringa S et al (2020) Persistent symptoms after Covid-19: qualitative study of 114 “long covid” patients and draft quality principles for services. BMC Health Serv Res 20(1):1144. https://doi.org/10.1186/s12913-020-06001-y (Published 2020 Dec 20)CrossRefPubMedPubMedCentral

14.

Sudre C, Murray B, Varsavsky T, et al (2020) Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. medRxiv 10.19.20214494; https://doi.org/10.1101/2020.10.19.20214494

15.

Halpin SJ, McIvor C, Whyatt G et al (2021) Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol 93(2):1013–1022. https://doi.org/10.1002/jmv.26368CrossRefPubMed

16.

Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Preprint. medRxiv. 2021.01.27.21250617. Published 2021 Jan 30. https://doi.org/10.1101/2021.01.27.21250617

17.

Carfì A, Bernabei R, Landi F (2020) Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. JAMA 324(6):603–605. https://doi.org/10.1001/jama.2020.12603CrossRefPubMedPubMedCentral

18.

Garrigues E, Janvier P, Kherabi Y et al (2020) Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect 81(6):e4–e6. https://doi.org/10.1016/j.jinf.2020.08.029CrossRefPubMedPubMedCentral

19.

Huang C, Huang L, Wang Y et al (2021) 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397(10270):220–232. https://doi.org/10.1016/S0140-6736(20)32656-8CrossRefPubMedPubMedCentral

20.

Goërtz YMJ, Van Herck M, Delbressine JM et al (2020) Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res 6:00542–02020. https://doi.org/10.1183/23120541.00542-2020CrossRefPubMedPubMedCentral

21.

Peghin M, Palese A, Venturini M et al (2021) Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients [published online ahead of print, 2021 Jun 7]. Clin Microbiol Infect. S1198–743X(21)00281–0. https://doi.org/10.1016/j.cmi.2021.05.033

22.

Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG (2021) Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung 199(2):113–119. https://doi.org/10.1007/s00408-021-00423-zCrossRefPubMed

23.

Augustin M, Schommers P, Stecher M et al (2021) Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 6:100122. https://doi.org/10.1016/j.lanepe.2021.100122CrossRefPubMedPubMedCentral

24.

Salamanna F, Veronesi F, Martini L, Landini MP, Fini M (2021) Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med (Lausanne) 8:653516. https://doi.org/10.3389/fmed.2021.653516 (Published 2021 May 4)CrossRef

25.

Vlachoyiannopoulos PG, Magira E, Alexopoulos H et al (2020) Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann Rheum Dis 79:1661–1663CrossRefPubMed

26.

Lerma LA, Chaudhary A, Bryan A, Morishima C, Wener MH, Fink SL (2020) Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19). J Transl Autoimmun 3:100073. https://doi.org/10.1016/j.jtauto.2020.100073CrossRefPubMedPubMedCentral

27.

Litwin CM, Binder SR (2016) ANA testing in the presence of acute and chronic infections. J Immunoassay Immunochem 37(5):439–452. https://doi.org/10.1080/15321819.2016.1174136CrossRefPubMed

28.

Derksen VFAM, Kissel T, Lamers-Karnebeek FBG, et al (2021) Onset of rheumatoid arthritis after COVID-19: coincidence or connected? [published online ahead of print, 2021 Mar 1]. Ann Rheum Dis. annrheumdis-2021–219859. https://doi.org/10.1136/annrheumdis-2021-219859

29.

Callow KA, Parry HF, Sergeant M, Tyrrell DA (1990) The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect 105(2):435–446. https://doi.org/10.1017/s0950268800048019CrossRefPubMedPubMedCentral

30.

Raman B, Cassar MP, Tunnicliffe EM et al (2021) Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine 31:100683. https://doi.org/10.1016/j.eclinm.2020.100683 (Published 2021 Jan 7)CrossRefPubMedPubMedCentral

31.

Liao B, Liu Z, Tang L et al (2021) Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19. Int J Med Sci 18(1):29–41. https://doi.org/10.7150/ijms.49728CrossRefPubMedPubMedCentral

32.

Marvisi M, Ferrozzi F, Balzarini L et al (2020) First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: factors predicting fibrotic evolution. Int J Infect Dis 99:485–488. https://doi.org/10.1016/j.ijid.2020.08.054)CrossRefPubMedPubMedCentral

33.

Joo YB, Lim YH, Kim KJ, Park KS, Park YJ (2019) Respiratory viral infections and the risk of rheumatoid arthritis. Arthritis Res Ther 21(1):199. https://doi.org/10.1186/s13075-019-1977-9CrossRefPubMedPubMedCentral

34.

Ono K, Kishimoto M, Shimasaki T et al (2020) Reactive arthritis after COVID-19 infection. RMD Open 6:e001350. https://doi.org/10.1136/rmdopen-2020-001350CrossRefPubMedPubMedCentral

35.

Gasparotto M, Framba V, Piovella C, Doria A, Iaccarino L (2021) Post-COVID-19 arthritis: a case report and literature review. Clin Rheumatol 40(8):3357–3362. https://doi.org/10.1007/s10067-020-05550-1CrossRefPubMedPubMedCentral

36.

Hønge BL, Hermansen MF, Storgaard M (2021) Reactive arthritis after COVID-19. BMJ Case Rep 14(3):e241375. https://doi.org/10.1136/bcr-2020-241375CrossRefPubMedPubMedCentral

37.

Petersen MS, Kristiansen MF, Hanusson KD, et al (2020) Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients [published online ahead of print, 2020 Nov 30]. Clin Infect Dis. ciaa1792. https://doi.org/10.1093/cid/ciaa1792

38.

Roongta R, Chattopadhyay A, Ghosh A (2021) Correspondence on ‘Onset of rheumatoid arthritis after COVID-19: coincidence or connected?’ [published online ahead of print, 2021 Apr 27]. Ann Rheum Dis. annrheumdis-2021–220479. https://doi.org/10.1136/annrheumdis-2021-220479

39.

Batur EB, Korez MK, Gezer IA, Levendoglu F, Ural O (2021) Musculoskeletal symptoms and relationship with laboratory findings in patients with COVID-19. Int J Clin Pract 75(6):e14135. https://doi.org/10.1111/ijcp.14135CrossRefPubMed

40.

Zhang Q, Shan KS, Minalyan A, O’Sullivan C, Nace T (2020) A rare presentation of coronavirus disease 2019 (COVID-19) induced viral myositis with subsequent rhabdomyolysis. Cureus 12(5):e8074. https://doi.org/10.7759/cureus.8074CrossRefPubMedPubMedCentral

41.

Beydon M, Chevalier K, Al Tabaa O, et al (2020) Myositis as a manifestation of SARS-CoV-2. Ann Rheum Dis https://doi.org/10.1136/annrheumdis-2020-217573. [Epub ahead of print: 23 Apr 2020].pmid:http://www.ncbi.nlm.nih.gov/pubmed/32327427

42.

Zhang H, Charmchi Z, Seidman RJ, et al (2020) COVID-19-associated myositis with severe proximal and bulbar weakness. Muscle Nerve 62:E57–60.https://doi.org/10.1002/mus.27003 pmid:http://www.ncbi.nlm.nih.gov/pubmed/32535934

43.

Chan KH, Farouji I, Abu Hanoud A, Slim J (2020) Weakness and elevated creatinine kinase as the initial presentation of coronavirus disease 2019 (COVID-19). Am J Emerg Med 38(7):1548.e1-1548.e3. https://doi.org/10.1016/j.ajem.2020.05.015CrossRef

44.

Rivera-Morales MD, Pell R, Rubero J, Ganti L (2020) Acute myopericarditis in the post COVID-19 recovery phase. Cureus. 12(10):e11247. https://doi.org/10.7759/cureus.11247 (Published 2020 Oct 29)CrossRefPubMedPubMedCentral

45.

Cares-Marambio K, Montenegro-Jiménez Y et al (2021) Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Chron Respir Dis 18:14799731211002240. https://doi.org/10.1177/14799731211002240CrossRefPubMedPubMedCentral

46.

Wu X, Liu X, Zhou Y et al (2021) 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med 9(7):747–754. https://doi.org/10.1016/S2213-2600(21)00174-0CrossRefPubMedPubMedCentral

47.

Dani M, Dirksen A, Taraborrelli P et al (2021) Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clinical medicine (London, England) 21(1):e63–e67. https://doi.org/10.7861/clinmed.2020-0896

48.

George PM, Barratt SL, Condliffe R et al (2020) Respiratory follow-up of patients with COVID-19 pneumonia. Thorax 75:1009–1016CrossRefPubMed

49.

Ojha V, Mani A, Pandey NN, Sharma S, Kumar S (2020) CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients. Eur Radiol 30(11):6129–6138. https://doi.org/10.1007/s00330-020-06975-7CrossRefPubMedPubMedCentral

50.

Wang Y, Dong C, Hu Y et al (2020) Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study. Radiology 296(2):E55–E64. https://doi.org/10.1148/radiol.2020200843CrossRefPubMed

51.

Deng L, Khan A, Zhou W et al (2020) Follow-up study of clinical and chest CT scans in confirmed COVID-19 patients. Radiol Infect Dis 7(3):106–113. https://doi.org/10.1016/j.jrid.2020.07.002CrossRefPubMedPubMedCentral

52.

Zhang H, Charmchi Z, Seidman RJ et al (2020) COVID-19-associated myositis with severe proximal and bulbar weakness. Muscle Nerve 62(3):E57–E60. https://doi.org/10.1002/mus.27003CrossRefPubMed

53.

Tabatabaei SMH, Rajebi H, Moghaddas F, Ghasemiadl M, Talari H (2020) Chest CT in COVID-19 pneumonia: what are the findings in mid-term follow-up? Emerg Radiol 27(6):711–719. https://doi.org/10.1007/s10140-020-01869-zCrossRefPubMed

54.

Mariano RZ, Rio APTD, Reis F (2020) Covid-19 overlapping with systemic sclerosis. Rev Soc Bras Med Trop. 53:e20200450. https://doi.org/10.1590/0037-8682-0450-2020 (Published 2020 Sep 21)CrossRefPubMedPubMedCentral

55.

Cao M, Zhang S, Chu D et al (2020) COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report. BMC Pulm Med 20(1):304. https://doi.org/10.1186/s12890-020-01335-zCrossRefPubMedPubMedCentral

56.

Schwartzberg LN, Advani S, Clancy DC, Lin A, Jorizzo JL (2021) A systematic review of dermatologic manifestations among adult patients with COVID-19 diagnosis. Skin Health Dis 1(2):e20. https://doi.org/10.1002/ski2.20CrossRefPubMedPubMedCentral

57.

McMahon DE, Gallman AE, Hruza GJ et al (2021) Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis 21(3):313–314. https://doi.org/10.1016/S1473-3099(20)30986-5CrossRefPubMedPubMedCentral

58.

Killion L, Beatty PE, Salim A (2021) Rare cutaneous manifestation of COVID-19. BMJ Case Rep. 14(1):e240863. https://doi.org/10.1136/bcr-2020-240863 (Published 2021 Jan 28)CrossRefPubMed

59.

Mehta P, Bunker CB, Ciurtin C et al (2021) Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy. Lancet Infect Dis 21(7):912. https://doi.org/10.1016/S1473-3099(21)00133-XCrossRefPubMedPubMedCentral

60.

Anders HJ, Sigl T, Schattenkirchner M (2001) Differentiation between primary and secondary Raynaud’s phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope. Ann Rheum Dis 60:407–409CrossRefPubMedPubMedCentral

61.

Mohabbat AB, Mohabbat NML, Wight EC (2020) Fibromyalgia and chronic fatigue syndrome in the age of COVID-19. Mayo Clin Proc Innov Qual Outcomes 4(6):764–766. https://doi.org/10.1016/j.mayocpiqo.2020.08.002CrossRefPubMedPubMedCentral

62.

Clauw D, Häuser W, Cohen S, Fitzcharles M (2020) Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain 161(8):1694–1697. https://doi.org/10.1097/j.pain.0000000000001950CrossRefPubMedPubMedCentral

63.

Wong TL, Weitzer DJ (2021) Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-a systemic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas) 57(5):418. https://doi.org/10.3390/medicina57050418 (Published 2021 Apr 26)CrossRef

64.

Graham EL, Clark JR, Orban ZS et al (2021) Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 “long haulers.” Ann Clin Transl Neurol 8(5):1073–1085. https://doi.org/10.1002/acn3.51350CrossRefPubMedPubMedCentral

65.

Ursini F, Ciaffi J, Mancarella L et al (2021) Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open 7:e001735. https://doi.org/10.1136/rmdopen-2021-001735CrossRefPubMed

66.

Wood E, Hall KH, Tate W (2021) Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 “long-haulers”? Chronic Dis Transl Med 7(1):14–26. https://doi.org/10.1016/j.cdtm.2020.11.002CrossRefPubMed

67.

González-Hermosillo JA, Martínez-López JP, Carrillo-Lampón SA et al (2021) Post-acute COVID-19 symptoms, a potential link with myalgic encephalomyelitis/chronic fatigue syndrome: a 6-month survey in a Mexican cohort. Brain Sci 11(6):760. https://doi.org/10.3390/brainsci11060760 (Published 2021 Jun 8)CrossRefPubMedPubMedCentral

68.

Grech S, Borg JN, Cuschieri S (2021) Back pain: An aftermath of Covid-19 pandemic? A Malta perspective [published online ahead of print, 2021 Jun 6]. Musculoskeletal Care. https://doi.org/10.1002/msc.1574.10.1002/msc.1574

69.

Liu Y, Sawalha AH, Lu Q (2021) COVID-19 and autoimmune diseases. Curr Opin Rheumatol 33(2):155–162. https://doi.org/10.1097/BOR.0000000000000776CrossRefPubMed

70.

Vojdani A, Vojdani E, Kharrazian D (2021) Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol 11:617089. https://doi.org/10.3389/fimmu.2020.617089CrossRefPubMedPubMedCentral

71.

Raveendran AV, Jayadevan R, Sashidharan S (2021) Long COVID: an overview. Diabetes Metab Syndr 15(3):869–875. https://doi.org/10.1016/j.dsx.2021.04.007)CrossRefPubMedPubMedCentral

72.

Raj SR, Arnold AC, Barboi A et al (2021) Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin Auton Res 31(3):365–368. https://doi.org/10.1007/s10286-021-00798-2CrossRefPubMedPubMedCentral

73.

Crook H, Raza S, Nowell J, Young M, Edison P (2021) Long covid-mechanisms, risk factors, and management. BMJ (Clinical research ed) 374:n1648. https://doi.org/10.1136/bmj.n1648CrossRef

74.

Watad A, De Marco G, Mahajna H et al (2021) Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines (Basel) 9(5):435. https://doi.org/10.3390/vaccines9050435 (Published 2021 Apr 29)CrossRef

75.

Terracina KA, Tan FK (2021) Flare of rheumatoid arthritis after COVID-19 vaccination. Lancet Rheumatol 3(7):e469–e470. https://doi.org/10.1016/S2665-9913(21)00108-9CrossRefPubMedPubMedCentral

76.

Nune A, Iyengar KP, Ish P, Varupula B, Musat CA, Sapkota HR (2021) Emergence of new onset SLE following SARS-CoV-2 vaccination, QJM, hcab229, https://doi.org/10.1093/qjmed/hcab229

Title: Long COVID from rheumatology perspective — a narrative review
Authors: Hem Raj Sapkota
Arvind Nune
Publication date: 01-02-2022
Publisher: Springer International Publishing
Keywords: Long-COVID Syndrome
Myalgie
Fibromyalgia
Myalgia
Fibromyalgia
COVID-19
Post-COVID Syndrome
Fatigue
Published in: Clinical Rheumatology / Issue 2/2022
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-021-06001-1

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Long COVID from rheumatology perspective — a narrative review

Abstract

ACC 2024 Congress Coverage

Highlights from the ACC 2024 Congress

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2022

Prevalence, clinical features, risk factors, and outcomes of SLE patients with aortic aneurysm: a cross-sectional retrospective study in a Chinese single center

Exposure-lag-response associations between extreme environmental conditions and primary Sjögren’s syndrome

Association of quantitative computed tomography ındices with lung function and extent of pulmonary fibrosis in patients with systemic sclerosis

Osteitis condensans ilii: prevalence and characteristics of a neglected mimic of sacroiliitis

Three-dimensional ultrasonographic imaging of Mikulicz’s disease

Hypertrophic pachymeningitis in polyarteritis nodosa: a case-based review

ACC 2024 Congress Coverage

Highlights from the ACC 2024 Congress

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page